CUE
Price
$0.34
Change
-$0.01 (-2.86%)
Updated
Jan 14 closing price
Capitalization
31.11M
68 days until earnings call
Intraday BUY SELL Signals
PYXS
Price
$1.99
Change
+$0.11 (+5.85%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
123.91M
69 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CUE vs PYXS

Header iconCUE vs PYXS Comparison
Open Charts CUE vs PYXSBanner chart's image
Cue Biopharma
Price$0.34
Change-$0.01 (-2.86%)
Volume$1.03M
Capitalization31.11M
Pyxis Oncology
Price$1.99
Change+$0.11 (+5.85%)
Volume$10.07K
Capitalization123.91M
CUE vs PYXS Comparison Chart in %
CUE
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CUE vs. PYXS commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUE is a Hold and PYXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CUE: $0.34 vs. PYXS: $1.99)
Brand notoriety: CUE and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CUE: 93% vs. PYXS: 69%
Market capitalization -- CUE: $31.11M vs. PYXS: $123.91M
CUE [@Biotechnology] is valued at $31.11M. PYXS’s [@Biotechnology] market capitalization is $123.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CUE’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • CUE’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, PYXS is a better buy in the long-term than CUE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CUE’s TA Score shows that 5 TA indicator(s) are bullish while PYXS’s TA Score has 4 bullish TA indicator(s).

  • CUE’s TA Score: 5 bullish, 3 bearish.
  • PYXS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CUE is a better buy in the short-term than PYXS.

Price Growth

CUE (@Biotechnology) experienced а -11.89% price change this week, while PYXS (@Biotechnology) price change was +40.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

CUE is expected to report earnings on Mar 24, 2026.

PYXS is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($124M) has a higher market cap than CUE($31.1M). PYXS YTD gains are higher at: 63.478 vs. CUE (11.657). CUE has higher annual earnings (EBITDA): -35.19M vs. PYXS (-83.07M). PYXS has more cash in the bank: 76.3M vs. CUE (18.7M). CUE has less debt than PYXS: CUE (6.17M) vs PYXS (19.1M). CUE has higher revenues than PYXS: CUE (7.1M) vs PYXS (2.82M).
CUEPYXSCUE / PYXS
Capitalization31.1M124M25%
EBITDA-35.19M-83.07M42%
Gain YTD11.65763.47818%
P/E RatioN/AN/A-
Revenue7.1M2.82M252%
Total Cash18.7M76.3M25%
Total Debt6.17M19.1M32%
FUNDAMENTALS RATINGS
CUE: Fundamental Ratings
CUE
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CUEPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CUE
Daily Signal:
Gain/Loss:
PYXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AGTT0.08N/A
N/A
Angstrom Technologies, Inc.
TSPCF1.78N/A
N/A
Cleanaway Waste Management Limited
TELNY14.11-0.16
-1.12%
Telenor ASA
TSGZF0.15N/A
-2.14%
TriStar Gold, Inc.
RCKHF0.88-0.07
-7.13%
Rockhopper Exploration Plc

CUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CUE has been loosely correlated with VCYT. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CUE jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CUE
1D Price
Change %
CUE100%
-2.74%
VCYT - CUE
36%
Loosely correlated
-1.39%
CRBU - CUE
34%
Loosely correlated
+1.26%
AXON - CUE
33%
Loosely correlated
-1.92%
PYXS - CUE
32%
Poorly correlated
+5.85%
AMRN - CUE
32%
Poorly correlated
-0.99%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with HOWL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then HOWL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-8.74%
HOWL - PYXS
42%
Loosely correlated
-0.56%
IPSC - PYXS
39%
Loosely correlated
+5.39%
BEAM - PYXS
38%
Loosely correlated
+2.55%
DAWN - PYXS
37%
Loosely correlated
-6.53%
BLRX - PYXS
37%
Loosely correlated
+0.35%
More